Development of targeted therapy of NRF2high esophageal squamous cell carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of targeted therapy of NRF2high esophageal squamous cell carcinoma
Authors
Keywords
Esophageal squamous cell carcinoma, NRF2
Journal
CELLULAR SIGNALLING
Volume 86, Issue -, Pages 110105
Publisher
Elsevier BV
Online
2021-08-04
DOI
10.1016/j.cellsig.2021.110105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comprehensive characterization of protein–protein interactions perturbed by disease mutations
- (2021) Feixiong Cheng et al. NATURE GENETICS
- Synthetic Lethality in Cancer Therapeutics: The Next Generation
- (2021) Jeremy Setton et al. Cancer Discovery
- Design, Synthesis, Characterization, and Crystal Structure Studies of Nrf2 Modulators for Inhibiting Cancer Cell Growth In Vitro and In Vivo
- (2021) Prathima Chikkegowda et al. ACS Omega
- Inhibitors of the protein–protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line
- (2020) Daisuke Yasuda et al. FREE RADICAL RESEARCH
- Regulation of NRF2 by Na+/K+-ATPase: implication of tyrosine phosphorylation of Src
- (2020) Le Ba Nam et al. FREE RADICAL RESEARCH
- Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
- (2020) Yongping Cui et al. CELL RESEARCH
- Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism
- (2020) Marie Angèle Cucci et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
- (2020) Liam Baird et al. MOLECULAR AND CELLULAR BIOLOGY
- Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells
- (2020) Xiaodan Sun et al. Oxidative Medicine and Cellular Longevity
- NRF2/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma
- (2020) Joab Otieno Odera et al. BIOCHEMICAL JOURNAL
- TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines
- (2020) Yan-Yi Jiang et al. GASTROENTEROLOGY
- A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue
- (2020) Brittany M. Bowman et al. JOURNAL OF PATHOLOGY
- Geldanamycin-Derived HSP90 Inhibitors Are Synthetic Lethal with NRF2
- (2020) Liam Baird et al. MOLECULAR AND CELLULAR BIOLOGY
- NRF2 Activation in Cancer: From DNA to Protein
- (2019) Erica W. Cloer et al. CANCER RESEARCH
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
- (2019) Fiona M. Behan et al. NATURE
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- The landscape of cancer cell line metabolism
- (2019) Haoxin Li et al. NATURE MEDICINE
- Potential Applications of NRF2 Inhibitors in Cancer Therapy
- (2019) Emiliano Panieri et al. Oxidative Medicine and Cellular Longevity
- Homoharringtonine stabilizes secondary structure of guanine-rich sequence existing in the 5′-untranslated region of Nrf2
- (2019) Jong-Su Kang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Impacts of NRF2 activation in non–small‐cell lung cancer cell lines on extracellular metabolites
- (2019) Daisuke Saigusa et al. CANCER SCIENCE
- A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance
- (2018) James H. Matthews et al. ACS Chemical Biology
- Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target
- (2018) Shaohua Ma et al. Annals of the New York Academy of Sciences
- NRF2 and the Hallmarks of Cancer
- (2018) Montserrat Rojo de la Vega et al. CANCER CELL
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment
- (2018) Sarah A. Best et al. Cell Metabolism
- Suppression of NRF2/ARE by convallatoxin sensitizes A549 cells to 5-FU-mediated apoptosis
- (2018) June Lee et al. FREE RADICAL RESEARCH
- Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation
- (2018) Hsiu-Yu Liu et al. INVESTIGATIONAL NEW DRUGS
- Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species
- (2018) Yuki Kitano et al. JOURNAL OF PATHOLOGY
- The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
- (2018) Masayuki Yamamoto et al. PHYSIOLOGICAL REVIEWS
- Modulating NRF2 in Disease: Timing Is Everything
- (2018) Matthew Dodson et al. Annual Review of Pharmacology and Toxicology
- RNAi/CRISPR Screens: from a Pool to a Valid Hit
- (2018) Anne Schuster et al. TRENDS IN BIOTECHNOLOGY
- Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus
- (2018) Junsheng Fu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration
- (2018) James M. McFarland et al. Nature Communications
- Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
- (2018) Martina Daga et al. PHYTOMEDICINE
- Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
- (2017) Kouhei Tsuchida et al. FREE RADICAL BIOLOGY AND MEDICINE
- Brusatol overcomes chemoresistance through inhibition of protein translation
- (2017) Bryan Harder et al. MOLECULAR CARCINOGENESIS
- CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells
- (2017) Q Wang et al. ONCOGENE
- A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
- (2017) E-J Choi et al. ONCOGENE
- Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells
- (2017) K Diehl et al. ONCOGENE
- Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus
- (2017) Takafumi Suzuki et al. Nature Communications
- Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors
- (2016) Anju Singh et al. ACS Chemical Biology
- Personalized and targeted therapy of esophageal squamous cell carcinoma: an update
- (2016) Yongjing Liu et al. Annals of the New York Academy of Sciences
- Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity
- (2016) Daisuke Yasuda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Somatically mutated ABL1 is an actionable and essential NSCLC survival gene
- (2016) E. Testoni et al. EMBO Molecular Medicine
- An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy
- (2016) Jiayu Zhu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Identification and Characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) Substrate
- (2016) Kathleen M. Mulvaney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nrf2 Transcription Factor Can Directly Regulate mTOR
- (2016) Gabriel Bendavit et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition
- (2016) E. H. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes
- (2016) David W Morgens et al. NATURE BIOTECHNOLOGY
- High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
- (2016) Channing Yu et al. NATURE BIOTECHNOLOGY
- Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer
- (2016) Evan C. Lien et al. NATURE CELL BIOLOGY
- Molecular biological correlation of fluorine-18 fluorodeoxyglucose uptake in esophageal squamous cell carcinoma
- (2016) Yasumitsu Hirose et al. NUCLEAR MEDICINE COMMUNICATIONS
- Suppression of NRF2–ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells
- (2016) Hui Peng et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma
- (2016) F Ahmad et al. Cell Death & Disease
- A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells
- (2016) Hilal S. Khalil et al. Oncotarget
- Chemoprevention of oxidative stress-associated oral carcinogenesis by sulforaphane depends on NRF2 and the isothiocyanate moiety
- (2016) Aixian Lan et al. Oncotarget
- Discovery of a novel Nrf2 inhibitor that induces apoptosis of human acute myeloid leukemia cells
- (2016) JinFeng Zhang et al. Oncotarget
- Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression
- (2016) Danyang Liu et al. Oncotarget
- A Small Molecule Inhibits Deregulated NRF2 Transcriptional Activity in Cancer
- (2015) Michael J. Bollong et al. ACS Chemical Biology
- Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention
- (2015) Bryan Harder et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Induction of NRF2-mediated gene expression by dietary phytochemical flavones apigenin and luteolin
- (2015) Ximena Paredes-Gonzalez et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway
- (2015) Alessandra Leone et al. FREE RADICAL BIOLOGY AND MEDICINE
- Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity—implications for therapeutic targeting of Nrf2
- (2015) Adedamola Olayanju et al. FREE RADICAL BIOLOGY AND MEDICINE
- 3′,4′,5′,5,7-Pentamethoxyflavone Sensitizes Cisplatin-Resistant A549 Cells to Cisplatin by Inhibition of Nrf2 Pathway
- (2015) Xiangyu Hou et al. MOLECULES AND CELLS
- The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance
- (2015) Alak Manna et al. PHYTOMEDICINE
- Personalized targeted therapy for esophageal squamous cell carcinoma
- (2015) Xiaozheng Kang WORLD JOURNAL OF GASTROENTEROLOGY
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
- (2015) B. Seashore-Ludlow et al. Cancer Discovery
- ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer
- (2015) Qiongrong Chen et al. Oncotarget
- Isoniazid prevents Nrf2 translocation by inhibiting ERK1 phosphorylation and induces oxidative stress and apoptosis
- (2015) Ajeet Kumar Verma et al. Redox Biology
- Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha
- (2014) Jiaguo Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells
- (2014) M Valenzuela et al. BRITISH JOURNAL OF CANCER
- Targeting ABL1-Mediated Oxidative Stress Adaptation in Fumarate Hydratase-Deficient Cancer
- (2014) Carole Sourbier et al. CANCER CELL
- Enhancing Reproducibility in Cancer Drug Screening: How Do We Move Forward?
- (2014) C. Hatzis et al. CANCER RESEARCH
- Esophageal Carcinoma
- (2014) Anil K. Rustgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nrf2 Negatively Regulates Melanogenesis by Modulating PI3K/Akt Signaling
- (2014) Jung-Min Shin et al. PLoS One
- A Review of the Evidence that Ochratoxin A Is an Nrf2 Inhibitor: Implications for Nephrotoxicity and Renal Carcinogenicity
- (2014) Alice Limonciel et al. Toxins
- Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination
- (2013) B. E. Hast et al. CANCER RESEARCH
- RXR Inhibits the NRF2-ARE Signaling Pathway through a Direct Interaction with the Neh7 Domain of NRF2
- (2013) H. Wang et al. CANCER RESEARCH
- Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway
- (2013) Ai-Mei Gao et al. CARCINOGENESIS
- The Potential of 11C-acetate PET for Monitoring the Fatty Acid Synthesis Pathway in Tumors
- (2013) Laura M. DeFord-Watts et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The Noncytotoxic Dose of Sorafenib Sensitizes Bel-7402/5-FU Cells to 5-FU by Down-Regulating 5-FU-Induced Nrf2 Expression
- (2013) Suna Zhou et al. DIGESTIVE DISEASES AND SCIENCES
- Isoniazid suppresses antioxidant response element activities and impairs adipogenesis in mouse and human preadipocytes
- (2013) Yanyan Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Comprehensive identification of mutational cancer driver genes across 12 tumor types
- (2013) David Tamborero et al. Scientific Reports
- Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes
- (2012) Chin-Shiu Huang et al. ARCHIVES OF TOXICOLOGY
- Roles of Keap1-Nrf2 System in Upper Aerodigestive Tract Carcinogenesis
- (2012) A. Ohkoshi et al. Cancer Prevention Research
- An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses
- (2012) Saelooom Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Wilms Tumor Gene on X Chromosome (WTX) Inhibits Degradation of NRF2 Protein through Competitive Binding to KEAP1 Protein
- (2012) Nathan D. Camp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function
- (2012) J. Ma et al. MOLECULAR AND CELLULAR BIOLOGY
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity
- (2012) A Arlt et al. ONCOGENE
- Suppression of the Nrf2-Dependent Antioxidant Response by Glucocorticoids and 11β-HSD1-Mediated Glucocorticoid Activation in Hepatic Cells
- (2012) Denise V. Kratschmar et al. PLoS One
- Global Gene Expression Profiling and Validation in Esophageal Squamous Cell Carcinoma and Its Association with Clinical Phenotypes
- (2011) H. Su et al. CLINICAL CANCER RESEARCH
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
- (2011) D. Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203
- (2010) Weijing Sun et al. JOURNAL OF CLINICAL ONCOLOGY
- Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression
- (2010) Ute Boettler et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
- (2010) Masaaki Komatsu et al. NATURE CELL BIOLOGY
- Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice
- (2009) Melinda S. Yates et al. CARCINOGENESIS
- Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
- (2009) Weimin Chen et al. MOLECULAR CELL
- Ochratoxin A impairs Nrf2-dependent gene expression in porcine kidney tubulus cells
- (2008) C. Boesch-Saadatmandi et al. JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
- (2008) T. Shibata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now